Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Therapeutic Advances in Pediatric Multiple Sclerosis.
Mood disorder as the presenting manifestation of demyelination.
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.
[New therapeutic options in multiple sclerosis].
PML in a patient with lymphocytopenia treated with dimethyl fumarate.
Pallidal and caudate volumes correlate with walking function in multiple sclerosis.
Epstein-Barr virus in multiple sclerosis.
Optimization of Magnetization-Prepared 3-Dimensional Fluid Attenuated Inversion Recovery Imaging for Lesion Detection at 7 T.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Disclosing a misdiagnosis of multiple sclerosis: do no harm?
Central auditory processing and word discrimination in patients with multiple sclerosis.
Epidemiology of Multiple Sclerosis in Iran: A Systematic Review.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
The determinants of depression in a Romanian cohort of multiple sclerosis patients.
Learning to swim, again: Axon regeneration in fish.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
Anthocyanin effects on microglia M1/M2 phenotype: Consequence on neuronal fractalkine expression.
Endocannabinoid signalling and the deteriorating brain.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.

Pages